SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $77,000 | -30.6% | 321,218 | +1.7% | 0.00% | – |
| Q4 2015 | $111,000 | -79.7% | 315,918 | +0.4% | 0.00% | -100.0% |
| Q3 2015 | $547,000 | -23.7% | 314,654 | -2.2% | 0.00% | 0.0% |
| Q2 2015 | $717,000 | +93.3% | 321,591 | +68.2% | 0.00% | – |
| Q1 2015 | $371,000 | -26.1% | 191,166 | +0.8% | 0.00% | -100.0% |
| Q4 2014 | $502,000 | -11.3% | 189,568 | +0.8% | 0.00% | 0.0% |
| Q3 2014 | $566,000 | -17.1% | 188,113 | +12.7% | 0.00% | 0.0% |
| Q2 2014 | $683,000 | +13.1% | 166,938 | +19.2% | 0.00% | 0.0% |
| Q1 2014 | $604,000 | -14.8% | 140,099 | +3.5% | 0.00% | 0.0% |
| Q4 2013 | $709,000 | -2.9% | 135,335 | +17.0% | 0.00% | 0.0% |
| Q3 2013 | $730,000 | +34.4% | 115,657 | +6.4% | 0.00% | 0.0% |
| Q2 2013 | $543,000 | – | 108,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |